1. Home
  2. WNEB vs ACHV Comparison

WNEB vs ACHV Comparison

Compare WNEB & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western New England Bancorp Inc.

WNEB

Western New England Bancorp Inc.

HOLD

Current Price

$13.94

Market Cap

264.8M

Sector

Finance

ML Signal

HOLD

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

HOLD

Current Price

$8.12

Market Cap

726.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WNEB
ACHV
Founded
1853
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
264.8M
726.5M
IPO Year
2001
2018

Fundamental Metrics

Financial Performance
Metric
WNEB
ACHV
Price
$13.94
$8.12
Analyst Decision
Buy
Strong Buy
Analyst Count
3
3
Target Price
$13.67
$14.67
AVG Volume (30 Days)
42.0K
1.4M
Earning Date
04-28-2026
05-11-2026
Dividend Yield
2.00%
N/A
EPS Growth
33.93
N/A
EPS
0.42
N/A
Revenue
$44,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$7.25
N/A
P/E Ratio
$32.90
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.78
$2.62
52 Week High
$15.01
$8.64

Technical Indicators

Market Signals
Indicator
WNEB
ACHV
Relative Strength Index (RSI) 53.46 60.88
Support Level $13.42 $4.03
Resistance Level $14.13 $8.63
Average True Range (ATR) 0.37 0.37
MACD 0.02 -0.01
Stochastic Oscillator 66.67 75.46

Price Performance

Historical Comparison
WNEB
ACHV

About WNEB Western New England Bancorp Inc.

Western New England Bancorp Inc through its bank subsidiary, provides a range of financial services to individuals and companies in western Massachusetts and northern Connecticut. These services include commercial lending, residential lending and consumer lending, checking, savings and time deposits, cash management, and wealth management. Substantially all of the company's revenues, profits, and assets are derived by the Bank from banking products and services.

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

Share on Social Networks: